CCM
BNTX icon

Covington Capital Management’s BioNTech BNTX Stock Holding History

Covington Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$7K Hold
50
– – ﹤0.01% 863
2022
Q2 		$7K Hold
50
– – ﹤0.01% 853
2022
Q1 		$9K Hold
50
– – ﹤0.01% 833
2021
Q4 		$13K Hold
50
– – ﹤0.01% 749
2021
Q3 		$14K Hold
50
– – ﹤0.01% 762
2021
Q2 		$11K Buy
+50
New +$9.43K ﹤0.01% 745

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Covington Capital Management's BNTX Position: Q3 2022 in Review

Covington Capital Management held its BioNTech (BNTX) position steady in Q3 2022 at 50 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #863.

Covington Capital Management first reported a position in BNTX in Q2 2021 and has held it in 6 quarters since. The position peaked at $14K in Q3 2021. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Covington Capital Management held 50 shares of BioNTech worth $7K as of Q3 2022.
  • Covington Capital Management left its BioNTech share count unchanged in Q3 2022.
  • BioNTech made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #863 holding.
  • Covington Capital Management first reported a position in BioNTech in Q2 2021 and has held it in 6 quarters since.
  • Covington Capital Management's BioNTech position peaked at $14K in Q3 2021.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.